Detailed instructions for the usage and dosage of Apelix

Alpelisib (Alpelisib), as a targeted therapy drug, plays an important role in the treatment of breast cancer. It is particularly suitable for adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced or metastatic breast cancer. In order to ensure that the drug can achieve optimal efficacy while reducing the risk of adverse reactions, it is crucial to correctly understand and master the usage and dosage of Apelix.

First of all, the dosage of Apelvis needs to strictly follow the doctor's recommendations. Under normal circumstances, adult patients with breast cancer need to take Apelvis once a day at a dose of 300 mg (two 150 mg tablets). This dose is determined based on the results of clinical trials and the patient's specific condition, so patients should not adjust the dose on their own.

Secondly, Apelvis needs to be taken with food. This is because food can affect the absorption and metabolism of the drug, and taking it with food can ensure that the drug reaches a stable concentration in the body to achieve optimal efficacy. Patients should take Apelvis at the same time each day with food to maintain stable concentrations of the drug in the body.

Patients also need to pay attention to some special matters when taking Apelvis. First, swallow the tablet whole. Do not chew, crush, or split the tablet before swallowing. Tablets should not be taken if they are broken, cracked, or incomplete. Secondly, if you miss a dose, you can take it with food within 9 hours of your usual dose. However, if it exceeds 9 hours, you should skip that day's dose and continue with your regular dose the next day.

Finally, patients should pay close attention to their body's reactions while taking Apelvis. If you have any symptoms or concerns, you should seek prompt advice from your doctor or medical professional.

Upon inquiry, Apelvis is not currently sold in the Chinese market, so patients in need need to turn to overseas markets for purchase. In the overseas market, the price of the original version of Apelvis in India is relatively high, about 5,000 yuan per box; while the generic drug of Lucius version in Laos has attracted the attention of many patients with its affordable price, about 2,000 yuan per box. Patients can choose a version that suits them based on their personal financial situation and actual needs.